YS Biopharma Co. Ltd. Ordinary Shares — Company Overview, News & Financial Data
YS Biopharma develops vaccines and therapeutic products, including advanced solutions for infectious diseases like COVID-19.
YS Biopharma Co. Ltd. Ordinary Shares
Company profile
About YS Biopharma Co. Ltd. Ordinary Shares
YS Biopharma (NASDAQ: YS) is a biopharma company listed on the NASDAQ stock exchange. The company focuses on developing, manufacturing, and commercializing innovative vaccines and therapeutic products. Key projects include its flagship PIKA adjuvant technology and a pipeline of next-generation vaccines targeting infectious diseases like COVID-19 and rabies. The main objectives are to improve global health through cutting-edge vaccines and to expand its product portfolio via research and development. YS aims to leverage its scientific expertise to address unmet medical needs and enhance the effectiveness of existing and new vaccines.
Snapshot
2010Year founded
773Employees
Beijing, ChinaHead office
Loading Map...
Global footprint
Operations
All Locations
People’s Republic of China
Products and/or services of YS Biopharma Co. Ltd. Ordinary Shares
- Pneumococcal Conjugate Vaccine: A key product designed to prevent pneumococcal infections, critical for immunization programs, particularly in children.
- Ebola Vaccine: Focuses on providing a robust solution for Ebola virus prevention, pivotal for controlling outbreaks in affected regions.
- Hepatitis B Vaccine: Essential for combating hepatitis B infections with strong immunogenicity, aimed at lowering global disease prevalence.
- Rabies Vaccine: Offers reliable post-exposure prophylaxis against rabies, vital for both human and veterinary use.
- Animal Vaccines: Broad range of vaccines targeting livestock diseases, enhancing animal health and agricultural productivity.
- Research and Development: Continuous efforts in innovative vaccine development, emphasizing future health solutions and technological advancements.
YS Biopharma Co. Ltd. Ordinary Shares executive team
- Mr. Gang LiHead of Marketing & Sales
- Dr. Yuan Liu Ph.D.Head of Vaccine Research
- Dr. Hui Shao Ph.D.President, CEO & Executive Director
- Ms. Chunyuan Wu CPAChief Financial Officer & Director
- Dr. Zenaida Reynoso MojaresChief Medical Officer
GET YOUR GRAFA EDGE NOW
Sign up free to follow this company
We'll switch on a 30-day Edge trial as a welcome gift